Singapore markets closed

Adamis Pharmaceuticals Corporation (ADMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2352-0.0124 (-5.01%)
At close: 04:00PM EDT
0.2398 +0.00 (+1.96%)
After hours: 06:52PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
794.888
2,209
16,527
22,114
15,087
Cost of revenue
5,383
6,872
14,894
15,479
9,798
Gross profit
-4,589
-4,663
1,634
6,635
5,289
Operating expenses
Research development
14,358
11,262
8,281
10,376
18,794
Selling general and administrative
15,280
16,144
30,581
25,288
25,948
Total operating expenses
29,638
27,406
38,861
35,664
44,742
Operating income or loss
-34,226
-32,069
-37,228
-29,029
-39,453
Interest expense
1.865
6.649
159.628
123.258
157.765
Total other income/expenses net
2,706
-2,523
-12,001
-322.106
-10.517
Income before tax
-31,506
-34,600
-49,389
-29,298
-39,376
Income tax expense
-
0.796
2.174
8.672
-369.34
Income from continuing operations
-31,506
-34,600
-49,391
-29,307
-39,007
Net income
-39,887
-45,828
-49,391
-29,307
-39,007
Net income available to common shareholders
-39,887
-45,828
-49,391
-29,307
-39,007
Basic EPS
-
-0.32
-0.64
-0.55
-1.00
Diluted EPS
-
-0.32
-0.64
-0.55
-1.00
Basic average shares
-
144,157
77,570
53,264
39,085
Diluted average shares
-
144,157
77,570
53,264
39,085
EBITDA
-
-33,157
-45,622
-26,230
-36,119